Related Experiment Video
Updated: Mar 25, 2026
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
4.1K
Inflammatory mediators in human epilepsy: A systematic review and meta-analysis
Evelien E de Vries1, Bart van den Munckhof1, Kees P J Braun1
1Brain Center Rudolf Magnus, Department of Pediatric Neurology, University Medical Center Utrecht, Utrecht, The Netherlands.
Neuroscience and Biobehavioral Reviews
|February 16, 2016
Summary
Inflammation plays a role in epilepsy. This review found elevated levels of certain inflammatory proteins in epilepsy patients, suggesting potential for anti-inflammatory treatments.
Area of Science:
- Neuroscience
- Immunology
- Pathophysiology
Background:
- Growing evidence implicates inflammation in the development of epilepsy.
- Understanding the role of inflammatory mediators is crucial for epilepsy research.
Purpose of the Study:
- To systematically review and meta-analyze studies on inflammatory mediators in human epilepsy.
- To identify specific inflammatory markers associated with epilepsy across different sample types.
Main Methods:
- Systematic review and meta-analysis of 66 articles.
- Inclusion of studies reporting inflammatory mediators in serum, cerebrospinal fluid, or brain tissue of epilepsy patients.
- Comparison of patient data with control groups for meta-analysis.
Main Results:
- Elevated levels of IL-1ra, IL-1β, IL-6, and CXCL8/IL-8 were observed in various epilepsy types and sample media.
- Specific proteins like IL-1α, IL-7, IL-13, and certain chemokines were increased exclusively in brain tissue.
- Meta-analysis revealed significant differences in serum IL-6, IL-17, and CSF IL-1β and IL-10 levels.
Conclusions:
- Inflammatory pathways are demonstrably involved in the pathophysiology of epilepsy.
- Further research can elucidate the precise roles of these pathways.
- Targeted anti-inflammatory therapies may offer future treatment potential for epilepsy.
